Article
Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.
FEMS immunology and medical microbiology - 28 Nov 2003
Derdelinckx Inge, Van Laethem Kristel, Maes Bart, Schrooten Yoeri, De Schouwer Kirsten, De Wit Stéphane, Fransen Katrien, García Ribas Sergio, Moutschen Michel, Vaira Dolores, Zissis Georges, Van Ranst Marc, Van Wijngaerden Eric, Vandamme Anne Mieke
Abstract excerpt
In this study we evaluated the performance of the VERSANT HIV-1 Resistance Assays (LiPA) in detecting drug resistance in therapy-naive HIV-infected patients diagnosed in Belgium in 2000. We compared the results with population sequencing and found concordance to be in line with previous studies in treatment-experienced patients (86.87% for reverse transcriptase (RT); 92.77% for protease (PRO)). Discordance was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.